Fact CheckerSign in

NCT06463795Completed

tDCS and Lower Limb Performance in Stroke

Effects of Transcranial Direct Current Stimulation on Lower Limb Performance in Stroke Patients

Source: ClinicalTrials.gov · Last updated 24 Mar 2025

Brief summary (registry, in English)

Lower limb rehabilitation is especially important, as the simple act of regaining the ability to walk has subsequent effects on the ability to engage in activities of daily living .So, this study will contribute in describing the management of lower limb motor recovery along with the therapeutic intervention (MRP) with tDCS (anodal stimulation). This study aims to address some of the drawbacks observed in previous studies like allocation concealment, small sample size due to drop outs, short term effects of tDCS and experimental designs as well.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
12 Jun 2024
Start date
1 Jul 2024
Primary completion date
31 Dec 2024
Lead sponsor
Riphah International University
Diseases
Stroke
NCT number
NCT06463795

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 1 Jul 2024 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Implanted medical devices including intracranial electrodes, surgical clips, shrapnel or a pacemaker

Other illness

  • Epilepsy
  • Patient with lower limb amputation or any MSK/neurological disorder that limit the LE function

Other

  • Scalp injury/ skin lesion e.g. psoriasis or eczema etc.

Who the study is looking for

  • Stroke for more than 6 months.
  • National Institutes of Health Stroke Scale (NIHSS) for severity level (Mild (1-4), Moderate (5-15), Moderate to Severe (16-20), Severe (21-42)

Age in the registry: 35 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pakistan Railway General Hospital
Coordinator of this site? Confirm its status
RawalpindiPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.